Overview:
Wounds inflicted by gunshots are very painful and life-threatening if not given immediate medical attention. Hemorrhage or profuse blood loss is the chief cause of mortality seen in military warfare. Rapid and effective management of hemorrhage is a lifesaving endeavor. There is currently an increase in the number of criminal violence and accidents occurring, which leads to mass killing and traumatic injury, propelling the growth of the gunshot wound injury treatment products market. Gunshot wound management is a critical procedure that involves observation, such as determining if there is a flash bleed, checking vital signs, and investigating if there is a burn to tissues, pallor, or swelling.
The Chicago Tribune, in its latest survey, has reported that each week in the United States, approximately 1,600 people are treated in trauma centers for gunshot wounds. The Brady report for 2016 states that in the United States, each year, 34,000 people die due to gunshot injuries, while 81,000 people survive. Post-World War II, the United States has been engaged in several wars in the Middle East and Afghanistan and has suffered tremendous casualties, with soldiers succumbing to gunshot wounds. In April 2014, the USFDA approved XSTAT 30, manufactured by RevMedx, Inc., a revolutionary hemostatic device that is used for the treatment of shrapnel and gunshot wounds. It consists of small groups of expanding sponges containing x-ray markers and is directly injected into the wound cavity. It temporarily creates a barrier for blood loss, providing hemostatic pressure, and is effective for 4 hours before the patient receives medical surgery.
The global gunshot injury treatment products market is classified as follows:
Product
Geography
- North America
- Europe
- United Kingdom
- Germany
- Rest of Europe
- Asia Pacific
- Japan
- China
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- rest of Latin America
- Middle East and Africa
- GCC
- Rest of the Middle East and Africa
Key players identified for the global gunshot injury treatment products market include:
The key players set to make a mark in the global gunshot wounds market are RevMedx, Inc. and Baxter Healthcare Corporation.
This report offers the following:
- A concise summary of the report titled “Gunshot Injuries Treatment Products Market” is as follows:
- For the scope of the report, historical information is taken for 2016, and 2017 is considered the base year. It helps in understanding the current market trends existing in the gunshot injury treatment products market for the duration of 2016 to 2026.
- Compound annual growth rate and market size are covered in the market assessment studies.
- The attractive investment proposition is covered for the market segments, which are by product and geography.
- The product portfolio segment covers critical information such as diverse products used for the management of gunshot wounds, financial information, and recent news coverage, which are covered under the company profiles section.
- The competitive landscape is given in the scope of the report to elucidate the existing competition in the gunshot injury treatment products market.
